publichealthupdate.com
''DELAMANID'' use in treatment of MDR-TB: WHO interim guidance
A new TB drug with a novel mechanism of action – delamanid - is now available for treatment of adults with multidrug-resistant tuberculosis (MDR-TB), a form
